News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
191,372 Results
Type
Article (9249)
Company Profile (22)
Press Release (182101)
Multimedia
Podcasts (3)
Webinars (2)
Section
Business (58937)
Career Advice (656)
Deals (11197)
Drug Delivery (21)
Drug Development (29030)
Employer Resources (40)
FDA (4961)
Job Trends (4571)
News (101860)
Policy (8105)
Tag
Academia (503)
Accelerated approval (2)
Adcomms (6)
Allergies (44)
Alliances (7923)
ALS (57)
Alzheimer's disease (578)
Antibody-drug conjugate (ADC) (68)
Approvals (5046)
Artificial intelligence (158)
Autoimmune disease (22)
Automation (9)
Bankruptcy (78)
Best Places to Work (4095)
BIOSECURE Act (3)
Biosimilars (65)
Biotechnology (21)
Bladder cancer (70)
Brain cancer (16)
Breast cancer (248)
Cancer (1665)
Cardiovascular disease (104)
Career advice (533)
Career pathing (7)
CAR-T (72)
CDC (6)
Cell therapy (200)
Cervical cancer (14)
Clinical research (26007)
Collaboration (470)
Company closure (1)
Compensation (334)
COVID-19 (840)
CRISPR (26)
C-suite (112)
Cystic fibrosis (43)
Data (1850)
Depression (27)
Diabetes (169)
Diagnostics (1842)
Digital health (10)
Diversity (1)
Diversity, equity & inclusion (10)
Drug discovery (50)
Drug pricing (30)
Drug shortages (11)
Duchenne muscular dystrophy (72)
Earnings (45404)
Editorial (13)
Employer branding (8)
Employer resources (35)
Events (28570)
Executive appointments (388)
FDA (5884)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (4)
Funding (439)
Gene editing (50)
Generative AI (4)
Gene therapy (166)
GLP-1 (364)
Government (1157)
Grass and pollen (3)
Guidances (167)
Healthcare (5300)
Huntington's disease (9)
IgA nephropathy (18)
Immunology and inflammation (68)
Immuno-oncology (4)
Indications (23)
Infectious disease (919)
Inflammatory bowel disease (58)
Inflation Reduction Act (3)
Influenza (26)
Intellectual property (42)
Interviews (125)
IPO (7161)
IRA (13)
Job creations (784)
Job search strategy (463)
Kidney cancer (10)
Labor market (18)
Layoffs (133)
Leadership (3)
Legal (1481)
Liver cancer (30)
Lung cancer (253)
Lymphoma (133)
Machine learning (5)
Management (10)
Manufacturing (135)
MASH (46)
Medical device (4072)
Medtech (4072)
Mergers & acquisitions (4449)
Metabolic disorders (408)
Multiple sclerosis (70)
NASH (6)
Neurodegenerative disease (55)
Neuropsychiatric disorders (18)
Neuroscience (922)
NextGen: Class of 2025 (1483)
Non-profit (1054)
Now hiring (6)
Obesity (197)
Opinion (44)
Ovarian cancer (47)
Pain (44)
Pancreatic cancer (63)
Parkinson's disease (96)
Partnered (3)
Patents (121)
Patient recruitment (66)
Peanut (20)
People (6836)
Pharmaceutical (6)
Pharmacy benefit managers (8)
Phase I (6724)
Phase II (11172)
Phase III (10175)
Pipeline (1196)
Policy (37)
Postmarket research (1068)
Preclinical (2104)
Press Release (27)
Prostate cancer (85)
Psychedelics (5)
Radiopharmaceuticals (82)
Rare diseases (200)
Real estate (894)
Recruiting (16)
Regulatory (6477)
Reports (16)
Research institute (488)
Resumes & cover letters (111)
Rett syndrome (8)
RNA editing (1)
RSV (25)
Schizophrenia (49)
Series A (67)
Series B (53)
Service/supplier (3)
Sickle cell disease (33)
Special edition (6)
Spinal muscular atrophy (87)
Sponsored (8)
Startups (633)
State (1)
Stomach cancer (6)
Supply chain (45)
Tariffs (13)
The Weekly (3)
Vaccines (312)
Venture capital (18)
Weight loss (118)
Women's health (15)
Worklife (8)
Date
Today (46)
Last 7 days (165)
Last 30 days (986)
Last 365 days (16817)
2025 (9374)
2024 (14759)
2023 (14315)
2022 (16776)
2021 (16234)
2020 (15541)
2019 (12785)
2018 (9784)
2017 (9333)
2016 (7966)
2015 (9632)
2014 (7086)
2013 (5215)
2012 (5911)
2011 (6161)
2010 (5233)
Location
Africa (217)
Alabama (13)
Alaska (2)
Arizona (52)
Arkansas (5)
Asia (12223)
Australia (2117)
California (3877)
Canada (1017)
China (336)
Colorado (169)
Connecticut (208)
Delaware (144)
Europe (29789)
Florida (455)
Georgia (97)
Hawaii (1)
Idaho (11)
Illinois (306)
India (10)
Indiana (163)
Iowa (10)
Japan (162)
Kansas (50)
Kentucky (11)
Louisiana (6)
Maine (37)
Maryland (397)
Massachusetts (2893)
Michigan (84)
Minnesota (193)
Missouri (43)
Montana (11)
Nebraska (4)
Nevada (42)
New Hampshire (28)
New Jersey (1136)
New Mexico (5)
New York (1042)
North Carolina (512)
North Dakota (3)
Northern California (1726)
Ohio (96)
Oklahoma (4)
Oregon (10)
Pennsylvania (723)
Puerto Rico (3)
Rhode Island (12)
South America (321)
South Carolina (10)
Southern California (1411)
Tennessee (53)
Texas (552)
United States (13677)
Utah (89)
Virginia (95)
Washington D.C. (33)
Washington State (329)
West Virginia (2)
Wisconsin (57)
191,372 Results for "6".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Lenalidomide Drug Market to Reach USD 22.04 Bn by 2032 with A Growth Rate of 6.6% – Report by Coherent Market Insights
June 18, 2025
·
1 min read
Press Releases
Cellectar Biosciences Announces Pricing of $6 Million Underwritten Public Offering
July 2, 2025
·
5 min read
Press Releases
MaxCyte to Report Second Quarter 2025 Financial Results on August 6, 2025
July 10, 2025
·
1 min read
Press Releases
Calidi Biotherapeutics Announces Exercise of Warrants for $4.6 Million of Gross Proceeds
July 10, 2025
·
5 min read
Press Releases
Certara to Report Second Quarter 2025 Financial Results on August 6th, 2025
July 9, 2025
·
1 min read
Press Releases
Adial Pharmaceuticals Announces Pricing of $3.6 Million Public Offering
June 18, 2025
·
6 min read
Press Releases
Biopharmaceutical Excipients Market Size to Surpass USD 6.60 Billion by 2034
June 23, 2025
·
1 min read
Press Releases
Ernexa Therapeutics Secures $6 Million in Second Closing Under Securities Purchase Agreement
June 24, 2025
·
4 min read
Press Releases
Abivax Announces Results of its June 6, 2025 Annual General Meeting
June 12, 2025
·
1 min read
Press Releases
Baxter Declares Quarterly Dividend - May 6, 2025
May 7, 2025
·
1 min read
1 of 19,138
Next
